These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30510509)

  • 1. Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects.
    Zhou Y; Hu P; Huang Y; Nuoer S; Song K; Wang H; Wen J; Jiang J; Chen X
    Front Pharmacol; 2018; 9():1316. PubMed ID: 30510509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects.
    Zhou Y; Hu P; Huang Y; Sang N; Song K; Wang H; Wen J; Jiang J; Chen X
    Front Pharmacol; 2019; 10():251. PubMed ID: 30941039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a pharmacokinetic and pharmacodynamic model for intranasal administration of midazolam in older adults: a single-site two-period crossover study.
    Barends C; den Daas I; Driesens M; Visser A; Absalom A; Colin P
    Br J Anaesth; 2023 Aug; 131(2):284-293. PubMed ID: 37268446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic properties of ciprofol emulsion in Chinese subjects: a single center, open-label, single-arm dose-escalation phase 1 study.
    Teng Y; Ou MC; Wang X; Zhang WS; Liu X; Liang Y; Zuo YX; Zhu T; Liu B; Liu J
    Am J Transl Res; 2021; 13(12):13791-13802. PubMed ID: 35035718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the Effect of Excitation on Depth of Anesthesia Monitoring in γ-Aminobutyric Acid Type A Receptor Agonist ABP-700.
    Valk BI; Eleveld DJ; Meyer P; Meier S; den Daas I; van Amsterdam K; Campagna JA; Sweeney SP; Absalom AR; Struys MMRF
    Anesthesiology; 2021 Jan; 134(1):35-51. PubMed ID: 33064833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and pharmacodynamics of brief etomidate infusion in healthy volunteers.
    Kaneda K; Yamashita S; Woo S; Han TH
    J Clin Pharmacol; 2011 Apr; 51(4):482-91. PubMed ID: 20498288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects.
    Zhou J; Leonowens C; Ivaturi VD; Lohmer LL; Curd L; Ossig J; Schippers F; Petersen KU; Stoehr T; Schmith V
    J Clin Anesth; 2020 Nov; 66():109899. PubMed ID: 32585566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
    Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
    J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part II. Pharmacodynamics of Electroencephalogram Effects.
    Eisenried A; Schüttler J; Lerch M; Ihmsen H; Jeleazcov C
    Anesthesiology; 2020 Apr; 132(4):652-666. PubMed ID: 31972657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics, and safety of ciprofol emulsion in Chinese subjects with normal or impaired renal function.
    Tao J; Liu S; Zhao YY; Qi L; Yan P; Wu N; Liu X; Liu D; Tian X
    Front Pharmacol; 2023; 14():1260599. PubMed ID: 38074142
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.
    Minto CF; Schnider TW; Egan TD; Youngs E; Lemmens HJ; Gambus PL; Billard V; Hoke JF; Moore KH; Hermann DJ; Muir KT; Mandema JW; Shafer SL
    Anesthesiology; 1997 Jan; 86(1):10-23. PubMed ID: 9009935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive pharmacokinetic and pharmacodynamic modelling to predict propofol effect using BIS-guided anesthesia.
    Martín-Mateos I; Méndez Pérez JA; Reboso Morales JA; Gómez-González JF
    Comput Biol Med; 2016 Aug; 75():173-80. PubMed ID: 27294779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of the short-acting sedative CNS 7056 in sheep.
    Upton RN; Somogyi AA; Martinez AM; Colvill J; Grant C
    Br J Anaesth; 2010 Dec; 105(6):798-809. PubMed ID: 20926479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population pharmacodynamic Markov mixed-effects model for determining remimazolam-induced sedation when co-administered with fentanyl in procedural sedation.
    Zhou J; Curd L; Lohmer LRL; Delpratt N; Ossig J; Schippers F; Stoehr T; Schmith VD
    Clin Transl Sci; 2021 Jul; 14(4):1554-1565. PubMed ID: 33768731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of recovery in patients undergoing intravenous conscious sedation using bispectral analysis.
    Sandler NA; Hodges J; Sabino M
    J Oral Maxillofac Surg; 2001 Jun; 59(6):603-11; discussion 611-2. PubMed ID: 11381378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
    Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
    Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single Ascending Bolus Dose.
    Struys MMRF; Valk BI; Eleveld DJ; Absalom AR; Meyer P; Meier S; den Daas I; Chou T; van Amsterdam K; Campagna JA; Sweeney SP
    Anesthesiology; 2017 Jul; 127(1):20-35. PubMed ID: 28459733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.